Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10720 | 973 | 26.0 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
782 | 11545 | CARDIOPLEGIA//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//CARIPORIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARDIAC PRESERVATION | Author keyword | 9 | 64% | 1% | 9 |
2 | PROVIDENCE HEART | Address | 7 | 41% | 1% | 14 |
3 | HYPOTHERMIC INJURY | Author keyword | 7 | 67% | 1% | 6 |
4 | WISCONSIN SOLUTION | Author keyword | 6 | 80% | 0% | 4 |
5 | ALBERT STARR | Address | 5 | 36% | 1% | 12 |
6 | ST THOMAS HOSPITAL CARDIOPLEGIC SOLUTION | Author keyword | 4 | 75% | 0% | 3 |
7 | HEART PRESERVATION | Author keyword | 3 | 26% | 1% | 11 |
8 | CADAVER HEART | Author keyword | 3 | 100% | 0% | 3 |
9 | MYOCARDIAL PRESERVATION | Author keyword | 3 | 23% | 1% | 12 |
10 | WUHAN HEART | Address | 3 | 42% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEART PRESERVATION | 30 | 56% | 4% | 36 |
2 | CARDIOPLEGIC SOLUTIONS | 17 | 47% | 3% | 26 |
3 | CARDIAC PRESERVATION | 13 | 48% | 2% | 20 |
4 | CARDIOPLEGIC SOLUTION | 12 | 38% | 3% | 25 |
5 | CRYSTALLOID CARDIOPLEGIC SOLUTION | 12 | 86% | 1% | 6 |
6 | MYOCARDIAL PRESERVATION | 11 | 38% | 2% | 24 |
7 | FACTOR MEDIATED FUNCTION | 11 | 100% | 1% | 6 |
8 | OF WISCONSIN SOLUTION | 11 | 16% | 6% | 61 |
9 | DONOR HEART PRESERVATION | 10 | 73% | 1% | 8 |
10 | THOMAS HOSPITAL SOLUTION | 8 | 70% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Normothermic donor heart perfusion: current clinical experience and the future | 2015 | 3 | 21 | 62% |
Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool | 2008 | 27 | 53 | 57% |
Retrograde heart perfusion: The Langendorff technique of isolated heart perfusion | 2011 | 59 | 31 | 19% |
Machine perfusion for cardiac allograft preservation | 2008 | 16 | 47 | 55% |
Current preservation technology and future prospects of thoracic organs. Part 2: heart | 2010 | 14 | 46 | 39% |
Endothelial damage during myocardial preservation and storage | 2002 | 27 | 79 | 51% |
The isolated blood and perfusion fluid perfused heart | 2000 | 94 | 9 | 22% |
Endothelial cell injury in cardiovascular surgery: The pathophysiology of vasomotor dysfunction | 1996 | 78 | 52 | 27% |
Effect of cardioplegic and organ preservation solutions and their components on coronary endothelium-derived relaxing factors | 2005 | 11 | 70 | 61% |
Experimental models for the study of cardiovascular function and disease | 2000 | 48 | 8 | 25% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROVIDENCE HEART | 7 | 41% | 1.4% | 14 |
2 | ALBERT STARR | 5 | 36% | 1.2% | 12 |
3 | WUHAN HEART | 3 | 42% | 0.5% | 5 |
4 | CARDIOTHORAC SURGCARDIOVASC | 1 | 38% | 0.3% | 3 |
5 | SWISS FDN ORGAN DONAT TRANSPLANTAT | 1 | 50% | 0.2% | 2 |
6 | STARR | 1 | 23% | 0.5% | 5 |
7 | CARDIOVASC CARDIOTHORAC SURG | 1 | 40% | 0.2% | 2 |
8 | DEV VASC BIOL PHARMACOL UNIT | 1 | 40% | 0.2% | 2 |
9 | HLTH SCI 1 | 1 | 21% | 0.3% | 3 |
10 | BETH ISRAEL DEACONESS MED CENTER | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000239152 | HTK SOLUTION//PRESERVATION SOLUTION//UW SOLUTION |
2 | 0.0000232417 | CARDIOPLEGIA//MYOCARDIAL PROTECTION//ANTEGRADE CARDIOPLEGIA |
3 | 0.0000118277 | PHYSIOL HYPOXIA//CHRONIC INTERMITTENT HYPOBARIC HYPOXIA//HYPOX CARDIOVASC PHYSIOL |
4 | 0.0000104091 | BRAIN DEATH//THER EUT END STAGE ORGAN DYSFUNCT//DONOR MANAGEMENT |
5 | 0.0000100672 | HETEROTOPIC CARDIAC TRANSPLANTATION//HEART TRANSPLANTATION HISTORY//DOMINIQUE LARREY |
6 | 0.0000096423 | SECC INSUFICIENCIA CARDIACA TRASPLANTE CARDIACO//SERV CARDIOL ADULTOS//LEFT HEART DISEASE |
7 | 0.0000081968 | ALPHA TOCOPHEROL ANALOG//MYOCARDIAL STUNNING//CORONARY ARTERY REPERFUSION |
8 | 0.0000080495 | LUNG PRESERVATION//EX VIVO LUNG PERFUSION//LUNG TRANSPLANTATION |
9 | 0.0000078268 | CALCIUM PARADOX//2 3 BUTANEDIONE MONOXIME//CREATINE KINASE RELEASE |
10 | 0.0000075241 | MACHINE PERFUSION//DONATION AFTER CARDIAC DEATH//HYPOTHERMIC MACHINE PERFUSION |